Slide 1: FY21 Full Year Results Investor Presentation
NUCHEV LIMITED (ACN 163 225 090) LEVEL 10, 420 ST KILDA ROAD MELB 3004 WWW.NUCHEV.COM.AU ASX CODE: NUC 30 August 2021 ASX Market Release FY21 Full Year Results Investor Presentation Nuchev Limited (ASX:NUC) attaches the Presentation to be delivered to Investors during briefings on the Company’s 2021
Slide 2: Nuchev Limited FY21 Full Year Results
Nuchev Limited FY21 Full Year Results August 2021
Slide 3: An Introduction to Nuchev
AN INTRODUCTION TO NUCHEV Established in 2013 ASX listing Dec 2019 Founded by CEO Ben Dingle, from four Major milestone in company’s growth generations of dairy farming strategy, following successful IPO Experts in goat-milk infant formula Capital raise Aug 2020 Rapidly growing segment of the global
Slide 4: Presenting Today / Agenda
PRESENTING TODAY AGENDA FY21 Review 3 Financial and business performance 4 Key financial and operational metrics 5 Ben Dingle Business strengths 6 CEO, Executive Director and Founder Strategy, execution and outlook 7 Appendix 8 Chantelle Pritchard COO, CFO and Company Secretary 2
Slide 5: FY2021 Review: COVID-19 Impacts
FY2021 Review COVID-19 IMPACTS FY21 saw the world continue to be challenged with the uncertainty and volatility created by the COVID-19 pandemic • Historically Daigou ~50% of total revenue DAIGOU • Channel disruption occurred rapidly with border closures and travel restrictions CONTRACTION • Consume
Slide 6: FY21 Financial & Business Performance
FY21 FINANCIAL & BUSINESS PERFORMANCE Volumes (Metric Tonnes) Full Year Results The results for the year reflect the challenging market 400 302 ▪ Net revenue of $10.9M was down 39% and volume of 370 MT was down 35% 300 199 ▪ Contraction of the Daigou trade had an adverse impact on the results, which
Slide 7: Key Financial and Operational Metrics
KEY FINANICIAL AND OPERATIONAL METRICS Commentary FY21 FY20 % change ▪ Net cash position remains strong with cash on hand of $14.5M Volume (MT) 1 370.2 568.1 (35%) ▪ Operating cash outflow improved year on year by $1.2M ▪ The net cash position allows the company to continue to invest in the high- gr
Slide 8: Business Strengths Remain in Place
BUSINESS STRENGTHS REMAIN IN PLACE GOAT INFANT FORUMULA GROWTH THROUGH PREMIUM AND COMPANY WELL CATEGORY GROWTH NEW MARKETS TRUSTED BRAND POSITIONED +10% +3% ▪ Global GIF market is growing and • China sales leading global trend of • Oli6® ranked the no.1 Toddler Milk • Flexible, capital light busine
Slide 9: Strategy, Execution and Outlook
STRATEGY, EXECUTION AND OUTLOOK Fundamentals remain compelling with outlook bright for the goat milk-based infant formula and nutrition category Attract new users to the brand BUILD BRAND • Brand centred on leadership in goat nutrition EQUITY • Bring to life our differentiated brand story leading wi
Slide 10: Appendix
APPENDIX 8
Slide 11: Consolidated Statutory Profit & Loss
CONSOLIDATED STATUTORY PROFIT & LOSS Notes 1. Revenue reflects the sale of GIF, other goat nutritional products, and raw ingredient sales. 2. Cost of sales include the costs to produce GIF and other goat products sold. 3. Other income comprises grants received and sundry income 4. General and admini
Slide 12: Consolidated Statutory Balance Sheet
CONSOLIDATED STATUTORY BALANCE SHEET COMMENTARY • A successful capital raise was completed in August 2020 of $14.3M (net of transaction costs), increasing issued capital and cash. • Working capital increased from $22.1m to $26.0M. • Intangibles assets decreased during the year as a result of impairm
Slide 13: Disclaimer
Disclaimer This presentation is provided by Nuchev Limited (ACN 163 225 090) (Nuchev) to provide summary information about Nuchev and its respective subsidiaries (together, the Group). Statements in this presentation are made as at the date of the presentation and the information in this presentatio
Slide 14: Slide 14